Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND JUN, P05412, 3725, ENSG00000177606, AP1, c-Jun
724 results:

  • 1. Select EZH2 inhibitors enhance viral mimicry effects of DNMT inhibition through a mechanism involving NFAT:AP-1 signaling.
    Chomiak AA; Tiedemann RL; Liu Y; Kong X; Cui Y; Wiseman AK; Thurlow KE; Cornett EM; Topper MJ; Baylin SB; Rothbart SB
    Sci Adv; 2024 Mar; 10(13):eadk4423. PubMed ID: 38536911
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Prediction of potential mechanisms of rhubarb therapy for colorectal cancer based on network pharmacological analysis and molecular docking.
    Yang F; Li X; Zhang Y; Ren Y; Zhang J; Xiao K
    Medicine (Baltimore); 2024 Mar; 103(12):e37477. PubMed ID: 38518016
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Caffeic acid phenethyl ester mediates apoptosis in serum-starved HT29 colon cancer cells through modulation of heat shock proteins and MAPK pathways.
    Yahya S; Sulaiman MK; Sudhandiran G
    Cell Biochem Funct; 2024 Mar; 42(2):e3942. PubMed ID: 38379263
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Small-molecule inhibition of MAP2K4 is synergistic with RAS inhibitors in
    Jansen RA; Mainardi S; Dias MH; Bosma A; van Dijk E; Selig R; Albrecht W; Laufer SA; Zender L; Bernards R
    Proc Natl Acad Sci U S A; 2024 Feb; 121(9):e2319492121. PubMed ID: 38377196
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. β-Lapachone induces ferroptosis of colorectal cancer cells via NCOA4-mediated ferritinophagy by activating JNK pathway.
    Zhao L; Miao H; Quan M; Wang S; Zhang Y; Zhou H; Zhang X; Lin Z; Piao J
    Chem Biol Interact; 2024 Feb; 389():110866. PubMed ID: 38218311
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Regorafenib monotherapy or combined with an immune-checkpoint inhibitor as later-line treatment for metastatic colorectal cancer: a multicenter, real-world retrospective study in China.
    Qu W; Liu Z; Chen X; Liu B; Zhao Y; Yan H; Qu X; Li S; Zang A; Sun Y; Zhu L; Zhou A
    BMC Cancer; 2024 Jan; 24(1):22. PubMed ID: 38166647
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Hepatic prohibitin 1 and methionine adenosyltransferase α1 defend against primary and secondary liver cancer metastasis.
    Fan W; Cao D; Yang B; Wang J; Li X; Kitka D; Li TWH; You S; Shiao S; Gangi A; Posadas E; Di Vizio D; Tomasi ML; Seki E; Mato JM; Yang H; Lu SC
    J Hepatol; 2024 Mar; 80(3):443-453. PubMed ID: 38086446
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Cooperation of MLL1 and jun in controlling H3K4me3 on enhancers in colorectal cancer.
    Lin X; Chen JD; Wang CY; Cai Z; Zhan R; Yang C; Zhang LY; Li LY; Xiao Y; Chen MK; Wu M
    Genome Biol; 2023 Nov; 24(1):268. PubMed ID: 38012744
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Fusobacterium nucleatum upregulates MMP7 to promote metastasis-related characteristics of colorectal cancer cell via activating MAPK(JNK)-ap1 axis.
    Ou S; Chen H; Wang H; Ye J; Liu H; Tao Y; Ran S; Mu X; Liu F; Zhu S; Luo K; Guan Z; Jin Y; Huang R; Song Y; Liu SL
    J Transl Med; 2023 Oct; 21(1):704. PubMed ID: 37814323
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Knockdown of
    Zeng Q; Zhang S; He L; Fu Q; Liao L; Chen L; Ding X
    Cancer Biother Radiopharm; 2024 Apr; 39(3):236-246. PubMed ID: 37782908
    [No Abstract]    [Full Text] [Related]  

  • 11. Critical role of heme oxygenase-1 in chaetoglobosin A by triggering reactive oxygen species mediated mitochondrial apoptosis in colorectal cancer.
    Sun WC; Lin CL; Lee TH; Chang CH; Ong AZ; Yeh YH; Yu CL; Chen GW; Hsieh YH; Wang SW
    Free Radic Biol Med; 2023 Nov; 208():833-845. PubMed ID: 37776916
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Analysis of a new therapeutic target and construction of a prognostic model for breast cancer based on ferroptosis genes.
    Li Q; Liu H; Jin Y; Yu Y; Wang Y; Wu D; Guo Y; Xi L; Ye D; Pan Y; Zhang X; Li J
    Comput Biol Med; 2023 Oct; 165():107370. PubMed ID: 37643511
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Regorafenib activates oxidative stress by inhibiting SELENOS and potentiates oxaliplatin-induced cell death in colon cancer cells.
    Yu Y; Wu T; Zhang X; Li P; Ye L; Kuang J; Tao L; Ni L; Zhao Q; Zhang J; Pan H; Xie C; Zheng C; Li S; Cui R
    Eur J Pharmacol; 2023 Oct; 957():175986. PubMed ID: 37598924
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. SNTB1 regulates colorectal cancer cell proliferation and metastasis through Yap1 and the WNT/β-catenin pathway.
    Zhang H; Li Z; Jiang J; Lei Y; Xie J; Liu Y; Yi B
    Cell Cycle; 2023 Sep; 22(17):1865-1883. PubMed ID: 37592763
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Knockdown of PTEN promotes colon cancer progression and induces M2 macrophage polarization in the colon cancer cell environment.
    Han X; Yan T; Wang L; He B; Yu H
    Indian J Pathol Microbiol; 2023; 66(3):478-487. PubMed ID: 37530327
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. c-jun-induced upregulation of LINC00174 contributes to colorectal cancer proliferation and invasion through accelerating USP21 expression.
    Liang W; Liu D; Wu J
    Cell Biol Int; 2023 Nov; 47(11):1782-1798. PubMed ID: 37434557
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Ceramide Analog 5cc Overcomes TRAIL Resistance by Enhancing JNK Activation and Repressing XIAP Expression in Metastatic Colon cancer Cells.
    Huang Q; Liu F
    Chemotherapy; 2023; 68(4):210-218. PubMed ID: 37429260
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. 7-Methoxyheptaphylline Enhances TRAIL-Induced Apoptosis of colorectal Adenocarcinoma Cell via JNK-Mediated DR5 Expression.
    Boonyarat C; Yenjai C; Reubroycharoen P; Chaiwiwatrakul S; Takomthong P; Pimsa P; Waiwut P
    Biol Pharm Bull; 2023 Aug; 46(8):1072-1078. PubMed ID: 37331805
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. jun-APOE-LRP1 axis promotes tumor metastasis in colorectal cancer.
    He L; Shi M; Ren S; Zhang J; Tian Y; Yang X; Liu H
    Biomol Biomed; 2023 Nov; 23(6):1026-1037. PubMed ID: 37310025
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Real-world treatment patterns and clinical outcomes for chemotherapy-based regimens in first-line MSI-H/dMMR metastatic colorectal cancer.
    Amonkar MM; Chase M; Myer NM; Wang T; Turzhitsky V; Spira A
    Cancer Treat Res Commun; 2023; 36():100712. PubMed ID: 37301728
    [TBL] [Abstract] [Full Text] [Related]  


    of 37.